Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.31 |
| ▸ | CA9 | Q16790 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.31 |
| ▸ | MGMT | P16455 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13695971 | 1.00 | CRBN (0.38) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL24795789 | 1.00 | CRBN (0.38) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL14922169 | 1.00 | CRBN (0.38) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL29787158 | 1.00 | CRBN (0.38) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL18886281 | 0.88 | CRBN (0.41) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL17282361 | 0.88 | CRBN (0.41) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL19164024 | 0.88 | CRBN (0.38) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL14922170 | 0.87 | CRBN (0.38) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL23234313 | 0.87 | CRBN (0.38) | CRBNMEN1KMT2ASMN1; SMN2TTR | |
| SCHEMBL18886307 | 0.87 | CRBN (0.38) | CRBNMEN1KMT2ASMN1; SMN2TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704915-A1 | LINKERS FOR DRUG CONJUGATES AND ANTIBODY DRUG CONJUGATES | BioAtla, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024226567-A1 | LINKERS FOR DRUG CONJUGATES AND ANTIBODY DRUG CONJUGATES | BIOATLA, INC. (US) | 2024-10-31 | — | — | WO | disclosed |